STOCKSCREENR
Log In

RDY

NYSE

Dr. Reddy's Laboratories Limited

$14.19+0.14(+1.00%)Mkt Cap: $11.81B

Key Stats

Market Cap

$11.81B

P/E Ratio

19.44

EPS

$0.73

Dividend Yield

0.61%

52-Week Range

$12.26 — $16.17

Volume

1.32M

Avg Volume

1.76M

Beta

0.31

Valuation

P/E (TTM)

19.44

Forward P/E

0.24

PEG Ratio

-5.55

P/S (TTM)

3.14

P/B (TTM)

2.92

P/FCF

291.87

EV/EBITDA

51.85x

EV/Sales

—

Financial Health

ROE (TTM)

0.16%

ROA (TTM)

0.10%

ROIC

0.04%

Gross Margin

0.55%

Operating Margin

0.19%

Net Margin

0.14%

Debt/Equity

0.21

Current Ratio

1.88

Growth

EPS Growth (YoY)

-0.14%

Revenue Growth (YoY)

+0.05%

EPS Growth (3Y)

+0.39%

EPS Growth (5Y)

+0.14%

Sales Growth (3Y)

+0.15%

Sales Growth (5Y)

+16.47%

EPS Est (This Year)

$59.84

EPS Est (Next Year)

$53.85

Dividends

Dividend Yield

—

Annual Dividend

$0.09

Payout Ratio

0.00%

Frequency

—

Ex-Dividend Date

2025-07-25

Cash/Share

$99.19

Analyst Consensus

3.0

Hold

1 = Strong Buy, 5 = Strong Sell

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

832.38M

Float

832.38M

Free Float %

100.00%

Technicals

RSI (14)

71.83

SMA 20

$13.57

SMA 50

$13.80

SMA 200

$14.24

ATR (14)

0.31

Volatility (Week)

0.01%

Volatility (Month)

0.01%

Pattern

—

Performance

1 Day

-0.99%

1 Week

+1.67%

1 Month

+4.78%

3 Months

+4.31%

6 Months

+1.59%

1 Year

—

YTD

+1.30%

All-Time High

$16.17

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

IN

Exchange

NYSE

IPO Date

2001-04-11

Employees

27048

CEO

Erez Israeli

Index Membership

—

Website

https://www.drreddys.com

Dr. Reddy's Laboratories Limited (RDY) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NYSE. With a market capitalization of $11.81B, a P/E ratio of 19.44, and a dividend yield of 0.61%, RDY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RDY against other stocks using dozens of fundamental and technical filters.

Similar Stocks

VTRS

Viatris Inc.

$13.80

+2.15%

$15.89B

INDV

Indivior Pharmaceuticals Inc

$31.33

+1.16%

$3.91B

AMRX

Amneal Pharmaceuticals, Inc.

$12.43

+4.10%

$3.91B

HCM

HUTCHMED (China) Limited

$14.30

+0.14%

$2.58B

SUPN

Supernus Pharmaceuticals, Inc.

$50.82

+1.21%

$2.93B

LNTH

Lantheus Holdings, Inc.

$80.45

+2.48%

$5.33B

Frequently Asked Questions

What is Dr. Reddy's Laboratories Limited's P/E ratio?

Dr. Reddy's Laboratories Limited (RDY) has a trailing twelve-month (TTM) P/E ratio of 19.44. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Dr. Reddy's Laboratories Limited pay a dividend?

No, Dr. Reddy's Laboratories Limited (RDY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Dr. Reddy's Laboratories Limited's market cap?

Dr. Reddy's Laboratories Limited (RDY) has a market capitalization of $11.81 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about RDY?

Wall Street analysts have a consensus "Hold" rating on Dr. Reddy's Laboratories Limited (RDY) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell).

How has RDY performed this year?

Dr. Reddy's Laboratories Limited (RDY) has returned +1.30% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.